Sandler Laura Lee: insider trades.
Sandler Laura Lee reported 8 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 6 sales ($1.0M), across 1 company.
- Transactions
- 8
- Purchases (P)
- 0
- Sales (S)
- 6
- Companies
- 1
- Name as filed
- Sandler Laura Lee
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | Officer · Chief Operating Officer | 8 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-15 | Oruka Therapeutics, Inc. | S | 906 | $95.71 | 235,478 | Form 4 |
| 2026-09-01 | Oruka Therapeutics, Inc. | M | 5,000 | $7.8 | 241,384 | Form 4 |
| 2026-09-01 | Oruka Therapeutics, Inc. | S | 4,000 | $92.01 | 236,384 | Form 4 |
| 2026-09-01 | Oruka Therapeutics, Inc. | S | 1,000 | $91.05 | 240,384 | Form 4 |
| 2026-07-01 | Oruka Therapeutics, Inc. | M | 5,000 | $7.8 | 241,384 | Form 4 |
| 2026-07-01 | Oruka Therapeutics, Inc. | S | 500 | $95.47 | 236,384 | Form 4 |
| 2026-07-01 | Oruka Therapeutics, Inc. | S | 2,263 | $94.75 | 236,884 | Form 4 |
| 2026-07-01 | Oruka Therapeutics, Inc. | S | 2,237 | $93.85 | 239,147 | Form 4 |
Questions
What stock did Sandler Laura Lee buy or sell?
Sandler Laura Lee reported 8 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 6 sales ($1.0M), across 1 company.
Is Sandler Laura Lee the same person as other filers with this name?
This page covers SEC CIK 2075401 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/sandler-laura-lee-2075401.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.